Kangstem Biotech Co., Ltd.

KOSDAQ:A217730 Rapporto sulle azioni

Cap. di mercato: ₩141.5b

Kangstem Biotech Gestione

Gestione criteri di controllo 0/4

Al momento non disponiamo di informazioni sufficienti sull'amministratore delegato.

Informazioni chiave

Jong-Cheon Na

Amministratore delegato

n/a

Compenso totale

Percentuale dello stipendio del CEOn/a
Mandato del CEOno data
Proprietà del CEOn/a
Durata media del managementNessun dato
Durata media del Consiglio di amministrazioneNessun dato

Aggiornamenti recenti sulla gestione

Recent updates

Is Kangstem Biotech (KOSDAQ:217730) Weighed On By Its Debt Load?

Sep 24
Is Kangstem Biotech (KOSDAQ:217730) Weighed On By Its Debt Load?

Is Kangstem Biotech (KOSDAQ:217730) Using Debt Sensibly?

May 24
Is Kangstem Biotech (KOSDAQ:217730) Using Debt Sensibly?

Investors Don't See Light At End Of Kangstem Biotech Co., Ltd.'s (KOSDAQ:217730) Tunnel

Mar 06
Investors Don't See Light At End Of Kangstem Biotech Co., Ltd.'s (KOSDAQ:217730) Tunnel

Is Kangstem Biotech (KOSDAQ:217730) Weighed On By Its Debt Load?

Feb 17
Is Kangstem Biotech (KOSDAQ:217730) Weighed On By Its Debt Load?

Would Shareholders Who Purchased Kang Stem Biotech's (KOSDAQ:217730) Stock Three Years Be Happy With The Share price Today?

Dec 26
Would Shareholders Who Purchased Kang Stem Biotech's (KOSDAQ:217730) Stock Three Years Be Happy With The Share price Today?

AMMINISTRATORE DELEGATO

Jong-Cheon Na

no data

Mandato

Jong-Cheon Na serves as Chief Executive Officer of Kangstem Biotech Co., Ltd.